Lymphopenia

15 registered clinical trials studyying Lymphopenia — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired P NCT07492875	ImmunityBio, Inc.	Phase 3
Recruiting	Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors NCT07258160	Second Affiliated Hospital of Soochow University	Phase 2
Not Yet Recruiting	PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0) NCT07267234	Second Affiliated Hospital of Soochow University	Phase 2
Recruiting	Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia Af NCT06181656	M.D. Anderson Cancer Center	—
Completed	Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma NCT06368349	Chang Gung Memorial Hospital	—
Completed	Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patient NCT04800731	Universitair Ziekenhuis Brussel	—
Completed	Etiology of Lymphopenia in Covid19 Infection NCT04404608	Dr Medhat Khafagy	—
Completed	Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19 NCT04910230	Qiang Hu	N/A
Completed	Stroke-induced Immunodepression in Neurorehabilitation NCT05889169	IRCCS National Neurological Institute "C. Mondino" Foundation	—
Terminated	Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas NCT02659800	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1
Completed	Lymphocyte Count as a Sign of Immunoparalysis and Its Correlation With Nutritional Status in Septic Pediatric NCT02698683	University of Sao Paulo	—
Withdrawn	Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant NCT01660347	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	N/A
Completed	Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal NCT00771810	Tarix Pharmaceuticals	Phase 2
Completed	Safety Study of IL-7 in HIV-infected Patients (Inspire) NCT00477321	Cytheris SA	Phase 1
Available	Expanded Access Use of Nogapendekin-alfa Inbakicept in the Reversal and Maintenance of Absolute Lymphocyte Cou NCT06956547	ImmunityBio, Inc.	—